Ahmedabad, Gujarat
GST No. 24AAIFO1327Q1ZZ
Call 07942674224 91% Response Rate
Send Enquiry
| Dose Strength | 25 mg |
| Manufacture By | Natco |
| Brand | Natco |
| Packaging Size | 1x30 tab |
| Packaging Type | Bottle |
View Complete details
| Dose/Strength | 300 mg |
| Packaging Size | 1x30Tablets |
| Packaging Type | Box |
| Manufacturer | Emcure |
| Usage / Application | Personal |
View Complete details
| Dose/Strength | 300 mg |
| Packaging Size | 1x30Tablets |
| Packaging Type | Box |
| Manufacturer | Emcure |
| Usage / Application | Personal |
View Complete details
| Packaging Size | 0.5 ml |
| Brand | Nexipox |
| Composition | Varicella Vaccine |
| Treatment | Prevension of chickenpox |
| Prescription/Non prescription | Prescription |
| Form | Injection |
Nexipox Vaccine is administered by a healthcare professional and should not be self-administered. It protects the child from diseases that can be caused by the varicella virus. It is given to children between 12 months to 12 years of age and the second dose after a minimum gap of 3 months. For adolescents and adults as well, it is given in two doses a minimum of 4 weeks apart.
Some common side effects of this medicine include mild pain, swelling, and redness at the site of injection, rashes, and low-grade fever. These are usually temporary and resolve with time. However, if these side effects do not go away with time or get worse, let the doctor know. The doctor may help with ways to reduce or prevent these symptoms.
View Complete details
| Strength | 0.5 mg |
| Pack Type | Box |
| Packaging Size | 1x30 tab |
| Brand Name | Xvir |
| Manufacturer | Natco |
| Country of Origin | Made in India |
View Complete details
| Strength | 600 mg |
| Packaging Size | 1x30 |
| Brand | Emcure |
| Composition | Efavirenz |
| Manufacturer | Emcure |
| Treatment | Manage HIV infection in adults and children when combined with other antiretroviral medicines |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
EFCURE 600MG TABLET contains Efavirenz which belongs to a group of medicines called Non-nucleoside reverse transcriptase inhibitors. EFCURE 600MG TABLET is used with other antiretroviral medicines to manage HIV (Human immunodeficiency virus) infection in adults and children (aged 3 months and above).
EFCURE 600MG TABLET is not recommended for use in patients allergic to Efavirenz. It is also not recommended for use in patients suffering from heart disease (such as changes in heart rate/rhythm, slow heartbeat, severe heart disease), and/or severe liver disease.
Before taking EFCURE 600MG TABLET, inform your doctor if you have a history of convulsion/fits/seizures, kidney problems (such as renal impairment), and/or other liver problems (such as chronic hepatitis B/C).
EFCURE 600MG TABLET is generally not recommended for use during pregnancy and in women planning for pregnancy since the medicine may cause harm to the unborn baby. Women of childbearing potential should effective contraceptive barriers while in management with EFCURE 600MG TABLET to manage accidental pregnancy. The medicine is also not recommended for use in breastfeeding women.
EFCURE 600MG TABLET is not recommended for use in children (aged less than 3 months) and also in children weighing less than 3.5 kg. The medicine is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
View Complete details
| Strength | 75 mg |
| Form | Tablet |
| Packaging Type | Strip |
| Brand | Natco |
| Manufactured By | Natco |
| Usage / Application | Personal |
View Complete details